TENAX THERAPEUTICS, INC. (TENX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-14

TENAX THERAPEUTICS, INC. (TENX) has filed 2 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-14. 6 Form 8-K material event filings were reported by TENX in the last 90 days. InsiderAlpha tracks every TENX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About TENAX THERAPEUTICS, INC. (TENX)

SEC CIK	0000034956

90-Day SEC Filing Activity

Form 4 filings (90d)	2
Form 8-K filings (90d)	6
Latest Form 4 filing	2026-07-14

Recent TENX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-07-13	Giordano Christopher Thomas	CEO	M — Option exercise	219	$3.55	$777	SEC
2026-07-13	Giordano Christopher Thomas	CEO	M — Option exercise	8.5K	$5.94	$50K	SEC
2026-05-11	STAAB THOMAS R II	Chief Financial Officer	A — Grant or award	10.0K	$0.00	—	SEC
2025-12-04	Rich Stuart	Chief Medical Officer	P — Open-market purchase	2.5K	$9.20	$23K	SEC
2025-12-03	Rich Stuart	Chief Medical Officer	P — Open-market purchase	1.5K	$9.08	$14K	SEC
2025-12-02	Rich Stuart	Chief Medical Officer	P — Open-market purchase	1.0K	$9.01	$9K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for TENAX THERAPEUTICS, INC. (TENX). Updated in real time as new filings are submitted to the SEC.

Most-Active TENX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Giordano Christopher Thomas	4	$51K
STAAB THOMAS R II	2	—

Recent TENX Form 8-K Material Events

2026-07-02 — Item 8.01, 9.01 [SEC]
2026-06-30 — Item 1.01, 9.01 [SEC]
2026-06-29 — Item 5.02, 8.01, 9.01 [SEC]
2026-06-04 — Item 5.07 [SEC]
2026-05-12 — Item 2.02, 9.01 [SEC]

Recent Insider Filings

2026-07-14 — Giordano Christopher Thomas (CEO)
2026-05-13 — STAAB THOMAS R II (Chief Financial Officer)
2026-02-03 — MCGAULEY THOMAS (Interim CFO)
2025-12-05 — Rich Stuart (Chief Medical Officer)
2025-11-20 — Giordano Christopher Thomas (CEO)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TENX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

TENX Insider Trading — FAQ

What is the latest insider trade for TENX?: TENAX THERAPEUTICS, INC. (TENX) had 2 insider filings in the last 90 days, with the most recent on 2026-07-14. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying TENX stock?: 0 insider purchases of TENX were filed in the last 90 days.
How many insiders are selling TENX stock?: 0 insider sales of TENX were filed in the last 90 days.
Where can I see TENX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every TENX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live TENX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.